课题基金 / 基金详情

Mechanism of B cell maturaion

Mechanism of B cell maturaion
B细胞成熟机制
批准号:
07457089
负责人:
TAKEMORI Toshitada
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

TAKEMORI Toshitada的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A/WySnJ mouse. a subline of A/J,is known to be deficient in B cell maturation. We observed in the present study that formation of the primary follicle in the spleen is deficient in A/WySnJ mouse, as compared to A/J,which could be associated with deficiency in signal cascade including MAPK/ERK in the B cells, resulting in poor response to CD40 and IgM stimulation in vitro.CD40 stimulation is essential for B cell activation and differentiation, such as class-switch, germinal center formation, and generation of memory. We observed in the present study that cd40 stimulation resulted in activation of MAPK/ERK via Ras-Raf-1-MEK signal pathway. The cytoplasmic tail of CD40 associates with TRAF2, TRAF3, TRAF5, and TRAF6. These TRAF proteins with exception for TRAF3 play a role in NF_KB activation in CD40 signaling. Our biochemical study showed that TRAF3 could inhibit MAPK/ERK activation in CD40 signaling. As overexpression of TRAF3 is known to suppress function of other TRAF proteins, the result is compatible with the idea that the TRAF protein as yet to be defined plays a role in MAPK/ERK activation in CD40 signaling.After activation, B cells enter into the primary follicles and establish germinal center. We observed that, in contrast to well-developed germinal center, Ig+ germinal center B cells are mostly in cell cycling. There cells expand and occupy germinal center at high frequency on day 7-8 after immunization ; however, these cycling B cells rapidly reduced the number on day 8-10 postimmunization.During that time these cells accumulate somatic hypermutation and could be selected by antigen. Rapidly cycling Ig+ germinal center B cells have potent antigen-presenting activity in vitro, suggesting that somatic hypermutation and antigen selection may operate simultaneously, probable via activation through T-cell interaction.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Misawa,Y.,Nagaoka,H.,Kimoto,H.,Kobayashi,M.,Shibuya,M.,and Takemori,T.: "CD43 expression in a B cell lymphoma,WEHI 231,reduces susceptibility to G1 arrest and extends survival in culture upon serum depletion." Eur.J.Immunol.26. 2573-2581 (1996)
Misawa,Y.、Nagaoka,H.、Kimoto,H.、Kobayashi,M.、Shibuya,M. 和 Takemori,T.:“B 细胞淋巴瘤中的 CD43 表达,WEHI 231,降低了对 G1 停滞的敏感性并延长了
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hagiwara,S.,Tsunetsugu-Yokota,Y.,Kimoto,H.and Takemori,T.: "Expression of VpreB3(8HS-20)molecules by alternative RNA processing." Int.Immunol.8. 1237-1244 (1996)
Hagiwara,S.、Tsunetsugu-Yokota,Y.、Kimoto,H. 和 Takemori,T.:“通过替代 RNA 处理表达 VpreB3(8HS-20) 分子。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hagiwara,S.,Tsunetsugu-Yokota,Y.,Kimoto,H.and Takemori,T.: "Expression of VpreB3 (8HS-20) molecules by alternative RNA processing." Int.Immunol.8. 1237-1244 (1996)
Hagiwara,S.、Tsunetsugu-Yokota,Y.、Kimoto,H. 和 Takemori,T.:“通过替代 RNA 加工表达 VpreB3 (8HS-20) 分子。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Memory B cell commitment, maintenance and terminal differentiation
    Molecular mechanism for memory B cell dynamics and survival
    • 批准号:
      15390164
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.6万
    • 财政年份:
      2003
    • 负责人:
      TAKEMORI Toshitada
    • 依托单位:
    Molecular events in the generation of memory B cells.
    • 批准号:
      13470076
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.61万
    • 财政年份:
      2001
    • 负责人:
      TAKEMORI Toshitada
    • 依托单位:
    The analysis of B cell differentiation and maturation
    • 批准号:
      02454196
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $3.97万
    • 财政年份:
      1990
    • 负责人:
      TAKEMORI Toshitada
    • 依托单位:
    国内基金
    海外基金
    EB病毒蛋白BZLF1上调CD40/CD40L- KU80/RAG信号通路促进BCR二次重排在机 体丧失自身免疫耐受的机制
    CD40激动剂介导巨噬细胞M1极化激活放疗旁观者效应的研究
    • 批准号:
      JCZRYB202500454
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    基于CD40/TAMS探究益气活血解毒方纳米囊泡诱导卵巢癌富脂微环境冷热转化免疫增效机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      卢雯平
    • 依托单位:
    基于前列腺癌类器官模型的B7H3靶向ADC药物与CD40协同免疫治疗研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      王晓婷
    • 依托单位: